FDA Approves First CAR T-cell Therapy
Yesterday marked a much anticipated milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced the...
Category: In the News
Yesterday marked a much anticipated milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced the...
Earlier this year, a study published in Cancer Discovery, a journal of the American Association for Cancer Research (AACR),...
As we learned recently, Senator John McCain was diagnosed with glioblastoma multiforme, an aggressive form of central nervous system...
As President of the American Association for Cancer Research (AACR), Michael A. Caligiuri, MD, is a strong advocate for...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a new molecularly targeted therapeutic called neratinib (Nerlynx)...
Hot on the heels of the FDA’s landmark approval of an anticancer therapeutic for use based on whether a...
The American Association for Cancer Research (AACR) has appeared in numerous publications lately, showcasing the breadth of our mission...
recent data suggest that there is another potential contender for a biomarker-based FDA approval: a targeted therapeutic called larotrectinib...
Tuesday marked a milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced its first approval...
At the end of last week, the U.S. Food and Drug Administration (FDA) approved expanding the use of pembrolizumab...